The creation of the Paul and Diane Manning Institute for Biotechnology will advance UVA's biomedical research, accelerate the development of new treatments and cures and ensure no Virginian needs to leave the state for even the most complex care.
Did you know Virginia has scorpions? I didn't.
A booster makes for longer-lasting antibodies, even for those who have had COVID-19, new research shows.
Our Ishan Williams, PhD, and Randall Moorman, MD, have received almost $6 million from the National Institutes of Health to capitalize on the untapped potential of artificial intelligence to improve critical care.
A surprise finding from our Wladek Minor should improve the process of drug development and help prevent harmful drug interactions.
Our Golam Mohi, PhD, has identified a promising new treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.